.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Percutaneous biopsy serves as a vital diagnostic tool for nephrologists today. However, clinicians must understand potential kidney biopsy complications when managing patients with diabetes. This population often faces unique challenges, such as vascular stiffness and hypertension. Recently, the TRIDENT study analyzed procedural safety in this cohort to provide better clinical guidance.
The researchers prospectively studied 408 native kidney biopsies across 21 sites in the United States. They used standardized definitions to ensure consistency in reporting. Consequently, the findings provide a clear picture of the safety profile for diabetic kidney disease. Overall, the study reported complications in 20% of cases. Notably, minor events like localized hematomas comprised most of these cases. Only 5% of procedures required intense resources like transfusions or surgical intervention.
The data highlighted several modifiable risk factors for practitioners to consider. For instance, an 18-gauge needle significantly reduced the odds of severe events compared to larger needles. Additionally, the operator's experience played a critical role in patient safety. Attending physicians maintained lower risk levels than fellows or hybrid teams. Interestingly, patients using renin-angiotensin system inhibitors (RAASi) showed fewer complications during the follow-up period.
However, certain non-modifiable factors also emerged from the analysis. Female sex correlated with a higher risk of major bleeding. Furthermore, the presence of a post-biopsy hematoma predicted more significant bleeding events later. While the number of needle passes led to hematoma formation, it did not affect adjusted major bleeding risk. In conclusion, kidney biopsies remain safe for adults with diabetes when performed with precision. Clinicians should focus on procedural optimization, smaller needles, and experienced oversight to improve patient safety.
The most common complication is the formation of a localized hematoma, occurring in about 15% of cases. Most of these events are minor and do not require intensive medical intervention.
Yes, research shows that using an 18-gauge needle significantly reduces the risk of resource-intense complications compared to a 16-gauge needle. Choosing a smaller gauge can improve the overall safety profile of the biopsy.
Experienced attending physicians are associated with significantly lower complication rates. Procedures led by trainees or hybrid teams often show a higher risk of bleeding and other adverse events.
Disclaimer: This content is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Mohandes S et al. Percutaneous Native Kidney Biopsy Complications in Diabetic Patients in the TRIDENT Cohort. Clin J Am Soc Nephrol. 2026 Jun 15. doi: 10.2215/CJN.0000001083. PMID: 42295857.
Hogan JJ, Owen JG, Blady SJ et al. The feasibility and safety of obtaining research kidney biopsy cores in patients with diabetes: an interim analysis of the TRIDENT Study. Clin J Am Soc Nephrol. 2020; 15(7):1024-1026.
Corapi KM et al. Bleeding complications of native kidney biopsy: a systematic review and meta-analysis. Am J Kidney Dis. 2012; 60(1):62-73.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A prospective analysis of the TRIDENT cohort reveals that while 20% of diabetic patients experience kidney biopsy complications, most events are minor. Key safety factors include using 18-gauge needles, ensuring experienced operators, and monitoring female patients more closely for major bleeding risks.
2 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
